Dr. Mehmet Oz, nominated to run the Centers for Medicare & Medicaid Services, will sell shares in Eli Lilly and UnitedHealth. Dr. Jay Bhattacharya, NIH nominee, will shed stock in Walmart and Nvidia.

Every time you get sick, your body keeps a record of it. It does so through your immune system, a vast army of cells that mobilizes to fight off diseases. And after the infection is over — if it’s ...

Incyte and Genesis Therapeutics have agreed to discover and optimize at least two initial small molecule compounds through Genesis’s AI platform, Genesis Exploration of Molecular Space (GEMS).

“Partnering with Genesis Therapeutics presents a unique opportunity to leverage their AI technologies to accelerate the ...

Fox Chase Cancer Center’s Cancer Epigenetics Institute will hold its fifth annual free hybrid Cancer Epigenetics Symposium at ...

NVIDIA (NASDAQ: NVDA) has introduced Evo 2, an advanced artificial intelligence (AI) system aimed at transforming the field ...

Plus: A shift in bird flu strategy, a new vaccine for meningococcal disease, a new AI genomics model from Nvidia and more.

The Sacramento-based health care giant bought Emery Yards, a 12-acre campus at Horton and 53rd Streets in Emeryville ...

Evo 2 now includes information from humans, plants, and other eukaryotic species to expand its capabilities in generative functional genomics.

The new doors AI and machine learning are opening to scientists undoubtedly will invite weighty ethical and moral questions ...

Boost Neuroscience is a stealth biotech with a proprietary synapse network platform based on the work of Nobel Laureate Dr. Thomas Südhof, M.D.

Researchers who have been given access to Google's new AI "co-scientist" tool are enthusiastic about its potential, but it ...